Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Clinical trial NCT04225871 · COMPLETED

Trial details

NCT number: NCT04225871
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Myasthenia Gravis

Start date: 2019-12-23
Primary completion: 2026-07-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.